New Shores for Antibodies?
Genentech Monoclonal Antibody Activates FGFR, Fights Diabetes
By Anette Breindl
Thursday, December 29, 2011
Ask most folks in biotech about their notion of a typical antibody, and it will probably be an antibody that blocks a receptor to fight cancer, or maybe autoimmune disease.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.